Quarterly Results

  • Company Name :
Zydus Lifesciences Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 532321
  • NSE Symbol:
  • ZYDUSLIFE
  • P/E(TTM):
  • 17.11
  • ISIN Demat:
  • INE010B01027
  • Div & Yield%:
  • 1.12
  • EPS(TTM):
  • 57.39
  • Book Value(₹):
  • 210.59
  • Market Cap(₹Cr.):
  • 98,787.02
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars March 2025 ( Cr)December 2024 ( Cr)September 2024 ( Cr)
Gross Sales 5,633.50 2,408.90 2,512.30
Excise Duty 0.00 0.00 0.00
Net Sales 5,633.50 2,408.90 2,512.30
Other Operating Income 186.10 107.00 108.30
Other Income 185.40 77.50 326.70
Total Income 6,005.00 2,593.40 2,947.30
Total Expenditure 2,046.90 1,867.40 1,678.40
PBIDT 3,958.10 726.00 1,268.90
Interest 155.40 97.20 95.90
PBDT 3,802.70 628.80 1,173.00
Depreciation 128.00 131.60 133.70
Tax 826.50 -24.20 248.60
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 34.50 50.80 0.90
Reported Profit After Tax 2,813.70 470.60 789.80
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 2,813.70 470.60 789.80
EPS (Unit Curr.) 27.96 4.68 7.85
EPS (Adj) (Unit Curr.) 27.96 4.68 7.85
Calculated EPS (Unit Curr.) 27.97 4.68 7.85
Calculated EPS (Adj) (Unit Curr.) 27.97 4.68 7.85
Calculated EPS (Ann.) (Unit Curr.) 111.88 18.71 31.40
Calculated EPS (Adj) (Ann.) (Unit Curr.) 111.88 18.71 31.40
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 100.60 100.60 100.60
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 70.26 30.14 50.51
PBDTM(%) 67.50 26.10 46.69
PATM(%) 49.95 19.54 31.44